Advertisement

Ocular Perfusion Pressure as a Risk Factor

  • Lina SiaudvytyteEmail author
Chapter

Abstract

The contribution of vascular deficits in glaucomatous optic neuropathy is based upon a recent increase in clinical data on vascular dysregulation involved in glaucoma pathology and was reflected by the World Glaucoma Association consensus on ocular blood flow in glaucoma. Inadequate or unstable ocular blood supply causes ischemic damage or reperfusion injury to the optic nerve head and axons. Ocular blood flow is dependent on perfusion pressure in the absence of vascular autoregulation. While in healthy subjects, autoregulation has been to maintain constant blood flow over a wide range of perfusion pressures.

References

  1. 1.
    Harris A, Werne A, Cantor LB. Vascular abnormalities in glaucoma: from population-based studies to the clinic? Am J Ophthalmol. 2008;145:595–7.CrossRefGoogle Scholar
  2. 2.
    Hayreh SS. Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res. 2001;20(5):595–624.CrossRefGoogle Scholar
  3. 3.
    Werne A, Harris A, Moore D, BenZion I, Siesky B. The circadian variations in systemic blood pressure, ocular perfusion pressure, and ocular blood flow: risk factors for glaucoma? Surv Ophthalmol. 2008;53(6):559–67.CrossRefGoogle Scholar
  4. 4.
    Flammer J, Mozaffarieh M. What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv Ophthalmol. 2007;52(Suppl 2):S162–73.CrossRefGoogle Scholar
  5. 5.
    Weinreb R, Harris A. Clinical revalence of ocular blood flow (OBF) measurements including effects of general medications of specific glaucoma treatment. In: Ocular blood flow in glaucoma. 6th ed. Amsterdam: Kugler; 2009. p. 60–126.Google Scholar
  6. 6.
    Liu JHK, Gokhale PA, Loving RT, Kripke DF, Weinreb RN. Laboratory assessment of diurnal and nocturnal ocular perfusion pressures in humans. J Ocul Pharmacol Ther. 2003;19(4):291–7.CrossRefGoogle Scholar
  7. 7.
    Caprioli J, Coleman AL. Blood pressure, perfusion pressure, and glaucoma. Am J Ophthalmol. 2010;149(5):704–12.CrossRefGoogle Scholar
  8. 8.
    Bonomi L, Marchini G, Marraffa M, Bernardi P, Morbio R, Varotto A. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology. 2000;107(7):1287–93.CrossRefGoogle Scholar
  9. 9.
    Leske MC. Ocular perfusion pressure and glaucoma: clinical trial and epidemiologic findings. Curr Opin Ophthalmol. 2009;20(2):73–8.CrossRefGoogle Scholar
  10. 10.
    Gherghel D, Orgul S, Gugleta K, Gekkieva M, Flammer J. Relationship between ocular perfusion pressure and retrobulbar blood flow in patients with glaucoma with progressive damage. Am J Ophthalmol. 2000;130(5):597–605.CrossRefGoogle Scholar
  11. 11.
    Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol (Chicago, IL: 1960). 2003;121(1):48–56.CrossRefGoogle Scholar
  12. 12.
    Tielsch JM, Katz J, Singh K, Quigley HA, Gottsch JD, Javitt J, et al. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol. 1991;134(10):1102–10.CrossRefGoogle Scholar
  13. 13.
    Leske MC, Connell AM, Wu SY, Hyman LG, Schachat AP. Risk factors for open-angle glaucoma. The Barbados Eye Study. Arch Ophthalmol (Chicago, IL: 1960). 1995;113(7):918–24.CrossRefGoogle Scholar
  14. 14.
    Hofman A, Breteler MMB, van Duijn CM, Krestin GP, Pols HA, Stricker BHC, et al. The Rotterdam Study: objectives and design update. Eur J Epidemiol. 2007;22(11):819–29.CrossRefGoogle Scholar
  15. 15.
    Harris A, Jonescu-Cuypers C, Martin B, Kagemann L, Zalish M, Garzozi HJ. Simultaneous management of blood flow and IOP in glaucoma. Acta Ophthalmol Scand. 2001;79(4):336–41.CrossRefGoogle Scholar
  16. 16.
    Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol (Chicago, IL: 1960). 1995;113(2):216–21.CrossRefGoogle Scholar
  17. 17.
    Quigley HA, West SK, Rodriguez J, Munoz B, Klein R, Snyder R. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol (Chicago, IL: 1960). 2001;119(12):1819–26.CrossRefGoogle Scholar
  18. 18.
    Zheng Y, Wong TY, Mitchell P, Friedman DS, He M, Aung T. Distribution of ocular perfusion pressure and its relationship with open-angle glaucoma: the Singapore Malay Eye Study. Invest Ophthalmol Vis Sci. 2010;51(7):3399–404.CrossRefGoogle Scholar
  19. 19.
    Memarzadeh F, Ying-Lai M, Chung J, Azen SP, Varma R. Blood pressure, perfusion pressure, and open-angle glaucoma: the Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci. 2010;51(6):2872–7.CrossRefGoogle Scholar
  20. 20.
    Orzalesi N, Rossetti L, Omboni S. Vascular risk factors in glaucoma: the results of a national survey. Graefes Arch Clin Exp Ophthalmol. 2007;245(6):795–802.CrossRefGoogle Scholar
  21. 21.
    Omoti AE, Enock ME, Okeigbemen VW, Akpe BA, Fuh UC. Vascular risk factors for open angle glaucoma in african eyes. Middle East Afr J Ophthalmol. 2009;16(3):146–50.CrossRefGoogle Scholar
  22. 22.
    Mitchell P, Lee AJ, Rochtchina E, Wang JJ. Open-angle glaucoma and systemic hypertension: the blue mountains eye study. J Glaucoma. 2004;13(4):319–26.CrossRefGoogle Scholar
  23. 23.
    Xu L, Wang YX, Jonas JB. Ocular perfusion pressure and glaucoma: the Beijing eye study. Eye (Lond). 2009;23(3):734–6.CrossRefGoogle Scholar
  24. 24.
    Leske MC, Wu S-Y, Hennis A, Honkanen R, Nemesure B. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology. 2008;115(1):85–93.CrossRefGoogle Scholar
  25. 25.
    Leske MC, Connell AM, Wu SY, Nemesure B, Li X, Schachat A, et al. Incidence of open-angle glaucoma: the Barbados Eye Studies. The Barbados Eye Studies Group. Arch Ophthalmol (Chicago, IL: 1960). 2001;119(1):89–95.Google Scholar
  26. 26.
    Hulsman CAA, Vingerling JR, Hofman A, Witteman JCM, de Jong PTVM. Blood pressure, arterial stiffness, and open-angle glaucoma: the Rotterdam study. Arch Ophthalmol (Chicago, IL: 1960). 2007;125(6):805–12.CrossRefGoogle Scholar
  27. 27.
    Ramdas WD, Wolfs RCW, Hofman A, de Jong PTVM, Vingerling JR, Jansonius NM. Ocular perfusion pressure and the incidence of glaucoma: real effect or artifact? The Rotterdam study. Invest Ophthalmol Vis Sci. 2011;52(9):6875–81.CrossRefGoogle Scholar
  28. 28.
    Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114(11):1965–72.CrossRefGoogle Scholar
  29. 29.
    Topouzis F, Coleman AL, Harris A, Jonescu-Cuypers C, Yu F, Mavroudis L, et al. Association of blood pressure status with the optic disk structure in non-glaucoma subjects: the Thessaloniki eye study. Am J Ophthalmol. 2006;142(1):60–7.CrossRefGoogle Scholar
  30. 30.
    Zhao D, He Z, Vingrys AJ, Bui BV, Nguyen CTO. The effect of intraocular and intracranial pressure on retinal structure and function in rats. Physiol Rep. 2015;3(8):e12507.CrossRefGoogle Scholar
  31. 31.
    Sehi M, Flanagan JG, Zeng L, Cook RJ, Trope GE. Relative change in diurnal mean ocular perfusion pressure: a risk factor for the diagnosis of primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2005;46(2):561–7.CrossRefGoogle Scholar
  32. 32.
    Choi J, Jeong J, Cho H-S, Kook MS. Effect of nocturnal blood pressure reduction on circadian fluctuation of mean ocular perfusion pressure: a risk factor for normal tension glaucoma. Invest Ophthalmol Vis Sci. 2006;47(3):831–6.CrossRefGoogle Scholar
  33. 33.
    Choi J, Kim KH, Jeong J, Cho H-S, Lee CH, Kook MS. Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for normal-tension glaucoma. Invest Ophthalmol Vis Sci. 2007;48(1):104–11.CrossRefGoogle Scholar
  34. 34.
    Costa VP, Jimenez-Roman J, Carrasco FG, Lupinacci A, Harris A. Twenty-four-hour ocular perfusion pressure in primary open-angle glaucoma. Br J Ophthalmol. 2010;94(10):1291–4.CrossRefGoogle Scholar
  35. 35.
    Okuno T, Sugiyama T, Kojima S, Nakajima M, Ikeda T. Diurnal variation in microcirculation of ocular fundus and visual field change in normal-tension glaucoma. Eye (Lond). 2004;18(7):697–702.CrossRefGoogle Scholar
  36. 36.
    Sung KR, Lee S, Park SB, Choi J, Kim ST, Yun S-C, et al. Twenty-four hour ocular perfusion pressure fluctuation and risk of normal-tension glaucoma progression. Invest Ophthalmol Vis Sci. 2009;50(11):5266–74.CrossRefGoogle Scholar
  37. 37.
    Sung KR, Cho JW, Lee S, Yun S-C, Choi J, Na JH, et al. Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure. Invest Ophthalmol Vis Sci. 2011;52(2):737–43.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Eye Clinic, Lithuanian University of Health SciencesKaunasLithuania

Personalised recommendations